Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.46% | 70.09% | -2,271.64% | 37.21% | -31.51% |
| Total Depreciation and Amortization | -27.02% | -25.70% | -4.70% | -4.44% | -5.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.25% | -548.01% | 150.53% | -90.58% | 251.94% |
| Change in Net Operating Assets | -295.85% | 169.92% | 121.92% | 73.79% | -128.08% |
| Cash from Operations | -9.00% | 46.75% | 49.09% | -20.09% | -56.66% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | 100.00% | -100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -78.57% | 1,260.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.24% | -- | -76.35% | -100.49% | -- |
| Cash from Financing | 856.97% | 71.50% | -78.48% | -94.92% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.65% | 48.25% | -88.97% | -73.72% | -46.75% |